We’re on a mission to improve health through fast and accurate diagnostics
Our story
The quicker we diagnose, the faster we can treat
Each day millions of physicians postpone prescribing medical treatment at because they lack timely access to accurate blood test results. The complexity and cost of small volume testing sees most blood samples returned following lengthy processing times, which can delay treatment for patients.
Our mission at Sight is to change this reality by providing affordable and accurate diagnostics in a compact platform designed for use in qualified labs in low volume settings. Our proprietary machine-vision based technology provides the capability to perform multiple tests on a single, easy-to-operate platform.
Our Team
{{member.name}}
{{selectedTeamMember.position}}
{{selectedTeamMember.text}}
Advisory Board
{{member.name}}
{{selectedAdvisoryBoardMember.position}}
{{selectedAdvisoryBoardMember.text}}
Invest
We're offering accredited investors a unique opportunity to invest in Sight and the future of blood diagnostics alongside venture and institutional co-investors.

Learn more through our partner OurCrowd.


Partners
Investors
Advisors
Janice M. Hogan
Co-director FDA Medical Device practice, Hogan Lovells US LLP
Gerard Herro
MS, PMP, Medical Research Manager, NAMSA
Joe Popowicz
Principal consultant, Emergent Clinical Consulting LLC
Designfields Dan Ram
Dan Ram
Product Design & User Experience